SPRO
Spero Therapeutics Inc
1.20$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +490.7% | +100.4% | +19.6% | +96.8% | -67.1% | +1,482.4% | +113.6% | -53.8% | +24.3% | |
| – | +239,290.9% | +24.8% | +3.1% | +94.1% | +1.9% | -98.3% | +38.5% | +3,225.1% | +88.1% | – | |
| – | – | – | +100.4% | +19.6% | +96.8% | -67.1% | +1,482.4% | +7.7% | -193.2% | – | |
| – | +136.7% | +24.8% | +3.1% | +94.1% | +1.9% | -3.7% | -26.2% | +8.1% | +88.1% | -60.2% | |
| – | +228.0% | +50.1% | +18.9% | +21.0% | +37.5% | +94.5% | -12.5% | -31.5% | -8.3% | -7.6% | |
| – | +151.8% | +24.4% | +2.6% | +58.8% | +30.1% | +2.9% | -0.3% | -66.0% | -20.3% | +142.6% | |
| – | – | – | – | – | – | – | – | – | -441.5% | – | |
| – | – | – | +0.0% | -100.0% | – | – | +34.3% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | -369.9% | – | |
| – | – | – | – | -165.6% | – | – | +4.4% | +61.1% | – | – | |
| – | – | – | – | – | – | – | – | – | -400.6% | – | |
| – | – | – | – | – | – | – | – | – | -366.9% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.